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BBA ^ Aims and Scope
Biochimica et Biophysica Acta publishes papers reporting ad-
vances in the knowledge or understanding of any ¢eld of bio-
chemistry or biophysics. More than forty volumes are published
each year, each section featuring the latest scienti¢c developments
in its ¢eld of interest. BBA publishes Regular papers, Rapid re-
ports, and Short functional sequence-papers and Promoter papers
which contribute new and signi¢cant information to the ¢elds of
biochemistry and biophysics. Negative results will be accepted
only when they can be considered to advance this knowledge
signi¢cantly. Papers providing only con¢rmatory evidence or ex-
tending observations ¢rmly established in one species to another
will not normally be accepted. The journal is divided into ten
specialized sections:
Bioenergetics covers the area of biological energy transfer and
conversion, focusing on the kinetics and thermodynamics of mo-
lecular mechanisms involved in photosynthesis, mitochondrial
and bacterial respiration, oxidative phosphorylation, motility
and transport, and mitochondrial pathophysiology, as well as
the underlying molecular structures. This section also includes
Reviews on Bioenergetics.
Biomembranes has its main focus on membrane structure,
function and biomolecular organization, membrane proteins,
receptors, channels and anchors, £uidity and composition,
model membranes and liposomes, membrane surface studies
and ligand interactions, transport studies, and membrane dynam-
ics.
Gene Structure and Expression covers DNA and RNA struc-
ture, DNA replication, damage and repair, gene rearrangements
and recombination, control of gene expression, transcription
mechanisms, RNA processing, cell cycle control, nucleic acid li-
gand interactions, DNA-modifying enzymes, viral systems and
molecular genetics. This section also includes Short functional
sequence-papers describing DNA and RNA sequences for protein
coding, regulatory or structural elements combined with signi¢-
cant functional studies, and Promoter papers describing sequence
and functional analysis of promoter and enhancer regions. Short
functional sequence-papers are also published in other sections of
BBA when this is more appropriate. This sections welcomes pa-
pers on functional genomics that provide signi¢cant experiments
that address the function of genes whose sequences and not func-
tion are already established.
General Subjects includes a wide diversity of papers and pro-
vides a vehicle for publication of novel and challenging subjects
in developing areas of research not yet established, as well as
completing BBA’s coverage of other important areas of biochem-
istry (glycobiology and novel compounds) and biophysics for
which no specialized section exists.
Molecular and Cell Biology of Lipids covers the novel aspects
of lipid biosynthesis and metabolism, including protein lipid
anchors, in all organisms. Emphasis is given to the enzymology
and molecular biology of the enzymes involved in lipid metab-
olism. In addition, molecular genetics of the genes involved will
be emphasized in the future.
Subsection: Lipids in Signalling and Recognition concentrates
on all biochemical and biophysical aspects of lipids and lipid-
derived messenger molecules, including their structure, physico-
chemical properties and transport, regulation and enzymology of
their biosynthesis and metabolic inactivation, and the recognition
processes underlying their biological activities.
Molecular Cell Research focuses on cellular processes at the
molecular level. These include aspects of intracellular tra⁄cking,
regulation of the secretory and endocytic pathways, sorting and
targetting, organisation and dynamics of cytoskeletal structures,
cellular interactions, cell cycle regulation, cell/tissue di¡erentation
and cellular enzymology. Also included are studies at the inter-
face between Cell Biology and Biophysics which apply for exam-
ple novel imaging methods for characterizing cellular processes.
Excluded, however, are studies describing purely cellular or phar-
macological aspects.
Subsection: Signal Transduction primarily focuses on hormone
and neurotransmitter action, receptor structure and regulation,
transmembrane signalling systems, second messengers, protein
phosphorylation, and calcium in signal transduction.
Protein Structure and Molecular Enzymology covers protein
structure, conformation and dynamics, protein^ligand interac-
tions, enzyme mechanisms, models and kinetics, physical proper-
ties and spectroscopy. This section also includes Short crystalli-
zation papers describing the crystallization of proteins.
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Manuscripts, the principal purpose of which is to describe the
puri¢cation of a protein, are considered outside the scope of
BBA. Concise and comprehensive reviews of recent developments
are considered for publication. However, authors are strongly
advised to consult with one of the Executive Editors before start-
ing a review.
Molecular Basis of Disease addresses the biochemistry and mo-
lecular genetics of disease processes and their models. The section
covers metabolic, membrane, receptor and immunological disor-
ders as well as viral, bacterial and parasitological disorders, and
includes the biochemistry of di¡erentiation disorders, tissue dam-
age and aging.
Reviews on Cancer is devoted to the rapid publication of crit-
ical views of leading investigators, who are invited to write on
subjects of high current interest in cancer research. The current
scope of this journal is the cell biology, genetics, and biochemis-
try of cancer, as well as the relationship of immunobiology to the
disease.
BBA Reviews. BBA also publishes Reviews that present a con-
cise yet comprehensive overview of recent developments in the
¢eld of interest in any other section. Reviews are usually submit-
ted on invitation.
Submission of manuscripts
A submission letter should always accompany the submitted
paper, providing the following information:
(a) The full name and address of the corresponding author (in-
cluding telephone and fax numbers, and e-mail address).
(b) Any known changes of address within a period of six months
after submission of the paper.
(c) The type of paper (Regular paper, Rapid report, Short func-
tional sequence-/Promoter paper or Review) and possibly a pre-
ferred section of the journal for eventual publication.
(d) The full title of the submitted paper.
(e) The names and addresses of at least three suitable potential
reviewers. If there are compelling reasons for excluding some
individuals as potential reviewers, these can be mentioned. How-
ever, choice of reviewers is at the editors’ discretion.
Four copies are required of all material submitted, including the
submission letter.
All ¢gures should be provided in quadruplicate and all four
sets of ¢gures should be labelled.
Copies of relevant papers that are submitted elsewhere or ‘in
press’, should be provided.
Manuscripts for publication in BBA should be mailed to one
of the Executive Editors via one of the receiving o⁄ces. [Four
copies of the hard-copy printout plus the electronic ¢le of the manu-
script.]
Editorial Secretariat
Biochimica et Biophysica Acta
P.O. Box 1345, 1000 BH Amsterdam
Molenwerf 1, 1014 AG Amsterdam
The Netherlands
Tel. : +31 (20) 485 3510
Fax: +31 (20) 485 3506
E-mail : bba@elsevier.nl
Biochimica et Biophysica Acta
Elsevier Science Inc.
275 Washington Street
Newton, MA 02458
USA
Tel. : +1 (617) 630 2244
Fax: +1 (617) 630 2245
E-mail : us_bba@elsevier.com
The Executive Editors are responsible for processing and profes-
sional review of the manuscripts. Authors are free in their choice
of an editorial o⁄ce, irrespective of their country of residence.
All materials submitted become the property of BBA. While
manuscripts and ¢gure copies of refused manuscripts will be re-
turned to the authors whenever possible, this cannot be guaran-
teed.
Submission of a manuscript implies that the work described
has not been published before (except in the form of an abstract
or as part of a published lecture or academic thesis), that it is not
under consideration for publication elsewhere, that its publication
has been approved by all the authors and tacitly or explicitly by
the responsible authorities in the laboratories where the work was
carried out and that, if accepted, it will not be published else-
where in the same form, in either the same or another language,
without the consent of the editors and the publisher. Reference
should be made to previously published abstracts, etc. in the
introductory section. Responsibility for the accuracy of the ma-
terial in the manuscript, including bibliographic citations, lies
entirely with the authors.
Ethics
When conducting scienti¢c research using human tissue and
which is intended for publication in BBA, authors should follow
procedures that are in accordance with the ethical standards as
formulated in the Helsinki Declaration of 1975 (revised in 1983).
When conducting experiments on animals, authors should follow
the institution’s or the National Research Council’s guide for the
care and use of laboratory animals.
Revisions and publication dates
Papers requiring revision and/or condensation will be returned
to the authors by the Executive Editors, specifying the requested
alterations and including the (anonymous) referee reports.
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Authors are requested to resubmit the revised paper within
6 months. Papers not resubmitted within six months will be
treated as new submissions.
Proofreading
Authors will receive proofs. Since acceptance is based upon the
submitted version of the paper, it is essential that no new material
be inserted in the text at the time of proofreading; furthermore,
no alteration to style or meaning will be permitted at this stage.
Any new material that the authors wish to introduce for reasons
of scienti¢c accuracy will be checked by the Executive Editors,
and a charge may be made for corrections. Authors are encour-
aged to return their proofs by fax especially in the case of Rapid
reports, Short functional sequence-papers and Promoter papers
where corrections must be faxed or e-mailed to the Publisher
within 48 hours of receipt.
O¡prints
Twenty ¢ve o¡prints are provided free of charge. There are no
page charges. An o¡print order form, price list and copyright
transfer form are sent upon receipt of the manuscript at the
Publisher so that extra o¡prints may be ordered. It is also essen-
tial that copyright be transferred at this stage.
Publication
Information concerning your accepted article can be ob-
tained from OASIS: On-line Article Status Information Sys-
tem (http://www.elsevier.com/oasis). This will provide you
with:
b general production status (in preparation, in proof, in issue),
b date of publication and o¡prints dispatch date,
b volume, issue and page numbers.
Electronic publishing
Authors are required to submit electronic manuscripts.
Type-setting from computer ¢les has several advantages, not
the least of which is the avoidance of re-keying errors in the
article.
The following points should be taken into account in preparing
electronic manuscripts:
1. Files produced by most commercial wordprocessing software
packages (but preferably WordPerfect) can be used directly by
the publisher. Save your ¢les as usual on a £oppy disk (the
preferred storage medium is a 5.25- or a 3.5-inch disk in the
MS-DOS (or compatible) system). Apple Macintosh or NEC is
also suitable; if you use NEC, please submit your article on a
double density or high density 5.25 inch disk or double density
3.5 inch disk (not a high density 3.5 inch disk). For other systems
please contact the BBA Editorial Secretariat ¢rst. Please do not
save your text as ASCII or similar: this will cause all special
formatting codes to be lost.
2. Authors should not use (or allow their word processor to
introduce) any hyphenation or word splits and they should not
use a ‘justi¢ed’ layout.
3. Authors should ensure that the digit ‘1’ and the letter ‘l’ (also
the digit ‘0’ (zero) and the capital letter ‘O’) have been used
properly. The letter X and the ‘times’ sign, the apostrophe and
the prime, and the hyphen and dash (for minus, etc.) represent
further sources of confusion.
4. If the word processor or printer has any special characters,
e.g., a«, G, e“, Ò, Greek letters and mathematical symbols, they
should be used consistently throughout the text.
5. Non-reproducible characters should not be left as blank spaces
in the ¢le, but should be replaced by characters or codes not used
elsewhere, and should be used consistently, e.g., sigma, cap for 4,
and sigma, l.c. for c. A list of such characters (codes) and a
lexicon of what they actually represent should be added as a
separate ¢le on the disk.
6. All instructions given on style and arrangement of Regular
papers should also be followed when preparing electronic manu-
scripts. This is especialy important for the References section.
Consistency in all operations is of vital importance in the prep-
aration of articles. Facilities for ‘automatic’ numbering of refer-
ences and footnotes must not be used.
7. In any case of doubt, authors are welcome to contact the
publisher before keying in an article.
The following points should be taken into account in submitting
electronic manuscripts:
1. The ¢le must contain the ¢nal corrected version of the article
and must match exactly the accompanying hard-copy printout ^
the ¢nal (revised) manuscript.
2. The output from speci¢c desk-top publishing (DTP) equipment
includes a considerable amount of coding which will interfere
with normal ¢le processing. Such DTP output should therefore
be avoided.
3. Four copies are required of the hard-copy printout.
4. Figures and tables are also handled electronically.
5. The disk should be labelled with:
^ the name of the author who will receive the proofs
^ the manuscript reference number (when known)
^ the soft- and hardware used
^ the names of the ¢les.
6. The disk and the four copies of the hard-copy printout should be
accompanied by a submission letter (see above).
7. Any revised version of a manuscript should be accompanied by a
new set of ¢gures and a disk containing the ¢nal revised version of
the paper.
BBA’s publications
BBA publishes English-language papers only. Papers may be
written in either American or British English, provided that the
preferred spelling is used consistently throughout.
Many readers of the journal are not native speakers of English.
It is therefore important to write succinctly and clearly, using
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short, simple sentences and avoiding long adjectival phrases and
laboratory jargon. The following types of paper are published:
Regular papers
A Regular paper is the normal medium of publication.
Although there is no ¢xed length, Regular papers should be as
concise as possible, while providing su⁄cient information for the
work to be repeated and for the claims of the authors to be
judged by the readers.
Rapid reports
Rapid reports should meet the following conditions:
(1) encompass a complete piece of work of special signi¢cance
and timeliness;
(2) be concise and not normally exceed 4 printed pages (i.e., up to
12 pages of double spaced typescript, including tables and ¢gures
up to a total number of 4);
(3) comprise no separate sections, except for a summary and the
reference list.
(4) should preferably be sent by e-mail in pdf format to one of the
receiving o⁄ces: bba@elsevier.nl (Amsterdam, The Netherlands);
us_bba@elsevier.com (Newton, MA, USA).
Authors should note that:
(a) Submission of a Rapid report should be accompanied by a
letter brie£y describing why the author believes his paper to be
deserving of rapid publication. Failure to provide this informa-
tion can lead to delays in the manuscript handling.
(b) An e-mail address or fax number must be given to enable
turnaround of corrected proofs within 48 h.
(c) Rapid reports will be added to the beginning of issues cur-
rently in production.
(d) An accepted Rapid report will generally be published within
8 weeks of the date of receipt at the Publisher’s o⁄ce, depending
on issue scheduling.
Short functional sequence-/Promoter papers
These are mainly published in the ‘Gene Structure and Expres-
sion’ section, and conform in style and format to BBA Rapid
reports. Short functional sequence-papers should provide infor-
mation on the function of the gene and include a comparison of
related sequences, a description of salient features of the sequence
and signi¢cant experimental data on function and expression of
the genes described. Papers presenting sequences presumably cod-
ing for a protein must be accompanied by su⁄cient evidence, e.g.
expression data, that the gene indeed codes for such a protein. If
the paper only con¢rms in one organism what is already known
for several other species, or describes sequences without informa-
tion on the function, it will not be considered eligible for publi-
cation in BBA. If the cDNA sequence has been published before,
BBA will not consider manuscripts describing the sequence of the
gene unless accompanied by functional studies on the promoter,
as in Promoter papers, or other functional data related to the
genomic organization and expression.
Promoter papers include data on promoter or enhancer se-
quences or other regulatory regions required for gene expression.
In addition to the sequence itself, these papers should include
novel information on the transcription start site and functional
studies, e.g., using reporter genes. Such studies could entail a
deletion analysis or otherwise establish functional regions in the
promoter that act either positively or negatively. In addition,
information on the recognition of these functional regions by
transcription factors could be included, e.g., using band shifts
or footprints.
Manuscripts should be marked ‘Short functional sequence-/
Promoter paper’ and the accompanying submission letter should
state explicitly that a Short functional sequence-/Promoter paper
is being submitted.
Sequences should be deposited in one of the usual data banks
before submission. Accession numbers should be mentioned in
the submission letter and in a footnote to the Short functional
sequence-/Promoter paper. In general accession numbers su⁄ce.
Only in exceptional cases, should the sequence be presented as a
¢gure.
Short crystallization papers
These are published in the BBA section on Protein Structure
and Molecular Enzymology and conform in style and format to
BBA Rapid reports. These short reports are intended for the
description of the crystallization of proteins for X-ray analysis.
They should o¡er novel information on the protein studied.
The protein should be of biochemical-biological importance
and not highly homologous to proteins of known structures, un-
less there is a particular reason why this might be interesting.
Unit cell dimensions and spacegroup determination and an esti-
mate of the resolution that can be obtained should be provided.
Correction of proofs follows that of other rapid publication
papers.
Reviews
BBA reviews are published in the independent section Reviews
on Cancer and in all other sections of the journal. They are
contributed by scientists who are leading specialists in their ¢eld
of expertise, normally at the invitation of the Executive Editors.
Authors wishing to contribute a review paper are advised ¢rst to
contact one of the responsible Executive Editors (listed in the
issues of BBA) to avoid overlap with Reviews already commis-
sioned.
Preparation of papers
Authors should consult a recent issue of the journal to make
themselves familiar with the conventions and layout of articles.
The entire text, including ¢gure and table legends and the
reference list, should be typed (or printed out) with double or
triple spacing on one side of the paper, leaving a left margin of
approx. 3 cm. All pages should be numbered consecutively, start-
ing with the title page of the manuscript. Every new paragraph
should be clearly indented. Handwritten characters should be
clearly de¢ned in the margin. Expressions of Latin origin, for
example, in vivo, in vitro, et al., per se, should be typed in
normal typeface. They should be neither italicized nor under-
lined.
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Equations should be numbered in the right margin as follows:
A B! C D 1
Title page
The title should be concise, descriptive and informative. The
names of the authors should be followed by their addresses and
indicated by corresponding letters. Changes in address should be
indicated by footnotes. The author(s) to whom correspondence
and proofs should be sent should be indicated, giving a full ad-
dress (including fax number and e-mail address).
Authors are requested to select a maximum of six key words
and to present them on the title page of the typescript. These key
words will be used in the compilation of the annual cumulative
index. They should cover precisely the contents of the submitted
paper and should give readers su⁄cient information as to the
relevance of the paper to his/her particular ¢eld.
Summary
The second page of the typescript should be reserved for the
Summary. This should be self-explanatory and intelligible with-
out reference to the body of the paper.
A Regular paper should have a Summary of 100^200 words;
Rapid reports and Short functional sequence-papers should have
summaries of approximately 50 words.
Since summaries are increasingly used by abstracting serv-
ices which will cut o¡ after a ¢xed number of words, it is
important not to exceed the maximum number of words and
to avoid bibliographic references and non-standard abbrevia-
tions.
Regular papers
After the Summary, Regular papers are usually divided into
the sections Introduction, Materials and methods, Results, Dis-
cussion and Acknowledgements.
Introduction
This is a short section in which the authors should state the
reasons for performing the work, with brief reference to relevant
previous work.
Materials and methods, Results, Discussion
The section Materials and methods should be detailed enough
for readers to reproduce the experiments. Authors should always
refer to other work on the same subject, indicating whether or
not their experimental results are in agreement with previous
work. Conclusions drawn from experiments described in the ta-
bles or ¢gures can often appear most conveniently in the Results
section. The overall conclusions based on the work reported
should be given in the Discussion. In shorter papers the Results
and Discussion sections may be combined.
Acknowledgements
Acknowledgements should be presented at the end of the main
text in a separate section.
Rapid reports, Short crystallization-, Short functional
sequence- and Promoter papers
These types of paper are not divided into sections after the
summary, except for the reference list. The ¢rst paragraph serves
as an introduction; acknowledgements are added as a ¢nal para-
graph before the reference list.
References and citations
The numerical system of references should be used. References
in the text should be cited by numbers in square brackets in the
order of their citation.
References are listed together in their order of appearance in a
separate section at the end of the text under the heading Refer-
ences. All references should be numbered consecutively. The
names of all authors (and of all editors in case of a multi-editor
volume) should be given in the References section. The names of
journals should be abbreviated according to the List of Serial
Title World Abbreviations (ISDS, Paris, 1985, ISBN 2-904938-
02-8).
BBA implements the recommendations of the Committee of
Editors of Biochemical Journals of the International Union of
Biochemistry concerning presentation of reference lists. Authors
should consult a current issue of BBA to acquaint themselves
with the general format.
Reference to a paper as ‘in press’ implies that it has been
accepted for publication. Evidence (e.g., a photocopy of the
note of acceptance from the journal concerned) should accom-
pany the submitted typescript. Papers that are ‘in press’ should be
included as a number in the text. Other papers submitted before
or simultaneously with the paper in question should be included
as a number in the text and in the References section, stating the
name of the journal. Copies of papers that are submitted else-
where should be provided for inspection by the Editors. Omission
of this information will delay publication and may lead to redat-
ing of a submitted manuscript. Papers presented at scienti¢c
meetings that are not available in published form should not be
cited as references in the References section.
Unpublished results should not be listed in the References sec-
tion. In the text they are mentioned as follows: ‘(M.V. Tervoort
and J. Glimcher, unpublished data)’. When unpublished results
are cited, the data should be provided for the Editors’ informa-
tion when essential for proper evaluation, or if requested.
A personal communication should be mentioned in the text as
follows: ‘(M.V. Tervoort, personal communication)’. Authors
should not make unauthorized use of personal communications.
Personal communications are not to be included in the Referen-
ces section.
Tables
Tables should be used sparingly; they should be used only
when the data cannot be presented clearly in the text. Authors
are requested to consult recent issues of BBA for the proper table
layout.
Each table, including its legend, should be typed on a separate
page. The heading of the table should make its general meaning
understandable without reference to the text.
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Figures and illustrations
Figures should be used to illustrate experimental results
clearly. As ¢gures are often reduced to a one-column width,
authors should bear in mind the size of BBA’s printed page
and they should ensure that symbols, lettering and lines are suf-
¢ciently large and clear to be legible after reduction. (Column
width is 8.4 cm, preferred ¢gure size is approximately double
this).
Legends should be collated and typed with double or triple
spacing on a separate sheet. A legend should consist of an open-
ing sentence constituting a brief title (without extra capitaliza-
tion), followed by a brief description of the ¢gure.
All ¢gures should be in a form suitable for reproduction, e.g.,
drawn in black, on waterproof drawing or tracing paper, or as
sharp, glossy prints. Each ¢gure should bear the ¢gure number,
the name of the corresponding author and the (shortened) title of
the paper on the reverse side. Figures should never be folded and
they should never be mounted on heavy card. Continuous or
half-tone ¢gures should have their labelling supplied as an over-
lay or be supplied in duplicate.
The size of symbols in relation to lettering should be chosen
carefully.
Photographs of gels, micrographs, etc., should be glossy and as
rich in contrast as possible. For photographs of electrophoretic
patterns and electron micrographs four high-quality prints must
be provided. If the content of a photograph is likely to su¡er as a
result of reduction, it should be provided in a size that will ¢t
within BBA’s format without reduction (preferred size is 8.4
cmU11 cm). In the case of electron micrographs, unit length
must be indicated on the ¢gure by a labelled bar.
When essential to the understanding of a paper, ¢gures may be
reproduced in colour, at the author’s own expense. The price of a
single printed full-colour page is EUR 340.00, exclusive of sales
tax. Two, three or four full-colour pages in combination will cost
EUR 227.00 per additional page excluding sales tax. Authors
should take into consideration that colour illustrations repro-
duced from a slide provide a better-quality, clearer result than
those reproduced from a photograph.
For complete up-to-date addresses of Editors please check the
link to the Editorial Board at www.bba-direct.com
m:/Iss/bbadis/1586#2/cover/notes.3d BBA notes 10-4-02 Versie d.d. 6/10/98.
Information for Contributors / Biochimica et Biophysica Acta 1586 (2002) 227^232232
